228 related articles for article (PubMed ID: 26076627)
1. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
Wang C; Huang H; Jia M; Jin S; Zhao W; Cha R
Carbohydr Polym; 2015 Oct; 130():275-9. PubMed ID: 26076627
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous investigation of the liquid transport and swelling performance during tablet disintegration.
Al-Sharabi M; Markl D; Mudley T; Bawuah P; Karttunen AP; Ridgway C; Gane P; Ketolainen J; Peiponen KE; Rades T; Zeitler JA
Int J Pharm; 2020 Jun; 584():119380. PubMed ID: 32407939
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
Sallam E; Ibrahim H; Dahab RA; Shubair M; Khalil E
Drug Dev Ind Pharm; 1998 Jun; 24(6):501-7. PubMed ID: 9876615
[TBL] [Abstract][Full Text] [Related]
4. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel superdisintegrants for pharmaceutical tableting based on functionalized nanocellulose hydrogels.
Sheikhy S; Safekordi AA; Ghorbani M; Adibkia K; Hamishehkar H
Int J Biol Macromol; 2021 Jan; 167():667-675. PubMed ID: 33249148
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different fast melting disintegrants by means of a central composite design.
Di Martino P; Martelli S; Wehrlé P
Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
[TBL] [Abstract][Full Text] [Related]
7. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
8. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
[TBL] [Abstract][Full Text] [Related]
9. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
Chaheen M; Soulairol I; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2017 Jul; 106(7):1839-1848. PubMed ID: 28392454
[TBL] [Abstract][Full Text] [Related]
10. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
[TBL] [Abstract][Full Text] [Related]
11. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
Yang B; Wei C; Yang Y; Wang Q; Li S
Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
[TBL] [Abstract][Full Text] [Related]
12. Effects of modification and incorporation techniques on disintegrant properties of wheat (Triticum aestivum) starch in metronidazole tablet formulations.
Odeniyi MA; Ayorinde JO
Polim Med; 2014; 44(3):147-55. PubMed ID: 25696939
[TBL] [Abstract][Full Text] [Related]
13. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
Zaheer K; Langguth P
Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
[TBL] [Abstract][Full Text] [Related]
14. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area.
Iwao Y; Tanaka S; Uchimoto T; Noguchi S; Itai S
Int J Pharm; 2013 May; 448(1):1-8. PubMed ID: 23518366
[TBL] [Abstract][Full Text] [Related]
15. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
[TBL] [Abstract][Full Text] [Related]
16. Fast disintegrating tablets containing Rhodiola rosea L. extract.
Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of quick disintegrating calcium carbonate tablets.
Fausett H; Gayser C; Dash AK
AAPS PharmSciTech; 2000 Jul; 1(3):E20. PubMed ID: 14727906
[TBL] [Abstract][Full Text] [Related]
19. Review of Disintegrants and the Disintegration Phenomena.
Desai PM; Liew CV; Heng PWS
J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of non-crystalline cellulose as a novel excipient in solid dose products.
Pawar K; Render D; Rangari V; Lee Y; Babu RJ
Drug Dev Ind Pharm; 2018 Sep; 44(9):1512-1519. PubMed ID: 29734848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
